1ISG-007 Economic savings from weight-based dosing of pembrolizumab: what is the impact in a tertiary hospital? by Mateos Egido, E, Dominguez Fariña, A, María, ÁMAttenya, Dorta Vera, D, Ruiz Santos, I, Lombardero Pin, M, Otero Villalustre, C, Luján López, ME, Fernández Vera, D

Get full text

3PC-051 Circuit to prepare and condition oral hazardous medicines by Benito Reyes, A, Otero Villalustre, C, Dorta Vera, D, Fernández Vera, D, Cruz, MÁ Perez, Montoya Matellanes, J, Dolz Bubbi, E, Lobardero Pin, M

Get full text

4CPS-017 Efficacy and safety of tolvaptan in the treatment of polycystic kidney disease by Majuelos Aicart, L, Lopez Bouzo, L, Damas Fuentes, RM, Otero Villalustre, C, Oliva Hernandez, L, Quesada Marques, V, Fernandez Vera, DF

Get full text

4CPS-248 Integration of a clinical pharmacist into a general surgery team: results evaluation by Majuelos, L, Sanchez, M Hathiramanni, Fuentes, RM Damas, Villalustre, C Otero, Lopez, T Lopez-Viñau, Leon, MV Morales

Get full text

4CPS-109 Experience of regorafenib use in metastatic colorectal cancer by Mateos, E, Alamo, AM, Vaswani, A Ramchandani, Pin, M Lombardero, López, ME Luján, García, JA Rodriguez, Villalustre, C Otero, Vera, D Fernandez

Get full text